Bellevalia eigii
Bellevalia eigii · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Bellevalia eigii is a plant species that has recently garnered scientific interest due to its diverse pharmacological potential. Research focusing on its organic extract has revealed significant biological activities, including anticancer and antimicrobial properties. Specifically, the plant demonstrates notable cytotoxic effects against colon cancer cells and melanoma lineages. Furthermore, studies have highlighted its effectiveness in targeting the pathogen Mycobacterium smegmatis. These findings suggest that Bellevalia eigii holds great promise as a source for developing new therapeutic agents.
- Synonyms
- Bellevalia Alexandrina
- Common names
- Not available
- Family
- Asparagaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Bellevalia eigii is a unique botanical specimen known by several distinct names across different linguistic traditions. In Russian-speaking regions, this plant is commonly referred to as Бельвалия Эйга. Similarly, it holds a recognized identity in Hebrew as זמזומית איג. These varied common names highlight the diverse cultural ways in which the species is classified and understood. Understanding these linguistic relationships is essential for anyone studying the global distribution of this plant.
Sources: Catalogue of Life (COL)
Synonyms
Bellevalia eigii is a botanical species that shares a close taxonomic connection with Bellevalia alexandrina. In many scientific records, these two names are treated as synonyms for the same plant. This overlap often occurs when different researchers identify the same organism under distinct labels. Understanding these nomenclature shifts is essential for maintaining accuracy in botanical databases. Consequently, identifying the correct name ensures that scientists can communicate clearly about this specific species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bellevalia eigii is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the order Asparagales, showcasing its specific evolutionary lineage. Further narrowing its botanical identity, the plant is a part of the family Asparagaceae. Finally, it is categorized under the genus Bellevalia, which defines its unique morphological characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Asparagaceae |
| Genus | Bellevalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bellevalia eigii is a distinctive plant species with a notable geographic range spanning multiple continents. Its distribution extends through parts of Northern Africa, including specific regions within Egypt. The species is also found across the Asia-Temperate zone, particularly throughout Western Asia. Within this broader area, it can be identified in the territories of Palestine and the Sinai Peninsula. This widespread presence highlights the plant's ability to thrive in various environments across these diverse landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bellevalia eigii is a delicate herb characterized by its distinct growth form. As a self-supporting plant, it maintains its own structure and posture within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bellevalia eigii has emerged as a significant subject of pharmacological interest due to the diverse bioactive compounds found within its bulbs. Research involving organic extracts from this native Jordanian plant has identified several homoisoflavonoids with potent cytotoxic properties. Specifically, these compounds have demonstrated promising anticancer potential when tested against melanoma and colon cancer cell lines. In addition to these effects, the plant exhibits notable antimicrobial activity, particularly against certain bacteria like Mycobacterium smegmatis. These multifaceted biological activities highlight the medicinal importance of Bellevalia eigii as a source for new therapeutic leads.
Compounds
Conditions
Bellevalia eigii contains bioactive compounds that demonstrate significant therapeutic potential against various pathogens and cancer types. Specifically, certain extracts from its bulbs exhibit antimicrobial activity against the bacterium Mycobacterium smegmatis. The plant also shows promise in treating colon cancer, with specific compounds showing high potency against the HT-29 cell line. Additionally, the chemical constituents of Bellevalia eigii are effective in addressing melanoma through their cytotoxic activities. These diverse biological properties highlight the plant's value in searching for new anticancer and antimicrobial leads.
Preparations
Bellevalia eigii is prepared as an organic extract specifically from its bulbs to facilitate chemical analysis. This extraction process was utilized as part of a scientific search for potential anticancer leads among the native plants of Jordan. Through this method, researchers were able to isolate eighteen different compounds, including several new homoisoflavonoids. These isolated substances were then subjected to various tests to determine their cytotoxic and antimicrobial properties. Consequently, the organic extract serves as the foundational source for identifying bioactive molecules like punctatins and bellegimycin.